thyroid cancer (Cancer)
Information
- Disease name
- thyroid cancer
- Disease ID
- DOID:1781
- Description
- "An endocrine gland cancer located in the thyroid gland located in the neck below the thyroid cartilage." [url:http\://en.wikipedia.org/wiki/Thyroid_gland]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04000880 | Active, not recruiting | N/A | Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health | March 4, 2020 | August 31, 2024 |
| NCT06051747 | Active, not recruiting | Phase 1/Phase 2 | Patient-Customized Bioprinting Technology for Practical Regeneration of the Respiratory Tract (Trachea) | July 17, 2023 | August 16, 2025 |
| NCT00673010 | Active, not recruiting | Phase 1 | Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma | March 2005 | March 2025 |
| NCT03215095 | Active, not recruiting | Early Phase 1 | RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers | July 10, 2017 | July 2024 |
| NCT03484884 | Active, not recruiting | A Study of Optical Imaging With Light From Radiotracers in Cancer Patients | March 20, 2018 | March 2025 | |
| NCT03345563 | Active, not recruiting | N/A | Project HERO: Health Empowerment & Recovery Outcomes | July 19, 2019 | December 31, 2030 |
| NCT01141309 | Active, not recruiting | Phase 2 | Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer | June 2010 | June 2025 |
| NCT04896580 | Active, not recruiting | N/A | IIT2020-20-SHIRAZIP-WALK: Nature Walks | June 21, 2021 | May 2024 |
| NCT05579782 | Active, not recruiting | N/A | Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy | October 5, 2022 | December 31, 2024 |
| NCT03285230 | Active, not recruiting | The French E3N Prospective Cohort Study | June 15, 1990 | December 15, 2025 | |
| NCT00410761 | Active, not recruiting | Phase 3 | An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer | November 30, 2006 | June 28, 2024 |
| NCT02938702 | Active, not recruiting | Active Surveillance on Papillary Thyroid Microcarcinoma | May 2016 | March 2030 | |
| NCT01709292 | Active, not recruiting | Phase 2 | Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer | November 7, 2012 | September 30, 2026 |
| NCT05328076 | Active, not recruiting | Parathyroid Vascularization During Total Thyroidectomy Using Indocyanine Green Angiography | May 2, 2022 | May 2024 | |
| NCT03196518 | Active, not recruiting | N/A | Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer | June 16, 2017 | June 2025 |
| NCT02657551 | Active, not recruiting | Phase 2 | A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer | January 2016 | December 2024 |
| NCT04552769 | Active, not recruiting | Phase 2 | Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer | September 10, 2020 | December 2024 |
| NCT03246958 | Active, not recruiting | Phase 2 | Nivolumab Plus Ipilimumab in Thyroid Cancer | October 3, 2017 | March 31, 2025 |
| NCT01398085 | Active, not recruiting | Phase 2/Phase 3 | IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients | May 2012 | March 2031 |
| NCT04544111 | Active, not recruiting | Phase 2 | PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer | September 2, 2020 | September 2, 2025 |
| NCT01412762 | Active, not recruiting | Measuring Patient Expectations for Thyroid Surgery | July 2011 | July 2024 | |
| NCT04521348 | Active, not recruiting | Phase 2 | Multiple Target Kinase Inhibitor and Anti-Programmed Death-1 Antibody in Patients With Advanced Thyroid Cancer | December 30, 2019 | June 30, 2024 |
| NCT04495985 | Active, not recruiting | CASE 1320: RAI Uptake and Serum Prolactin in Thyroid Cancer | July 14, 2020 | August 2024 | |
| NCT05796258 | Active, not recruiting | Three-pronged Centralized Molecular Analysis to Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer | July 26, 2021 | June 30, 2024 | |
| NCT01496313 | Active, not recruiting | Phase 4 | To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer | August 28, 2012 | June 28, 2024 |
| NCT03533361 | Approved for marketing | Expanded Access Program With Lenvatinib for the Treatment of Differentiated Thyroid Cancer in Brazil | |||
| NCT04566393 | Available | Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies | |||
| NCT01025453 | Completed | Phase 2 | Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer | December 1, 2009 | January 16, 2018 |
| NCT06429514 | Completed | N/A | Study on the Mechanism of Ganoderma Lucidum Spore Powder in the Treatment of Depression | March 28, 2023 | May 3, 2024 |
| NCT01074684 | Completed | Predictive Factors of Clinical, Laboratory and Imaging Findings Routinely Used in Diagnosing Thyroid Cancer | January 2010 | December 1, 2021 | |
| NCT01083550 | Completed | Phase 2/Phase 3 | Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer | February 2010 | November 2016 |
| NCT01089335 | Completed | Sentinel Lymphnode in Patients With Papillary Thyroid Carcinoma and in Patients With Suspected Thyroid Neoplasia | March 2010 | December 2018 | |
| NCT01102127 | Completed | Elastography in Thyroid Nodules | February 2010 | September 2010 | |
| NCT01135849 | Completed | B-Receptor Signaling in Cardiomyopathy | November 2008 | October 2010 | |
| NCT06423105 | Completed | Influencing Factors and Prediction Model of False-negative Central Lymph Nodes in Thyroid Cancer Patients | January 1, 2013 | April 1, 2024 | |
| NCT01173289 | Completed | Phase 2 | Study of External Beam Radiotherapy to Thyroid Carcinoma | December 2009 | August 2015 |
| NCT00121628 | Completed | Phase 2 | A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer | July 2005 | October 2010 |
| NCT01270321 | Completed | Phase 2 | Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer | November 2010 | February 2019 |
| NCT05175404 | Completed | Phase 2 | Use of 18F-PSMA-11 PET for Detection of Lesions in Iodine Refractory Thyroid Cancers | January 24, 2022 | July 18, 2023 |
| NCT01325857 | Completed | N/A | Analgesic Efficacy of Bilateral Superficial Cervical Plexus Block in Robot-assisted Endoscopic Thyroidectomy Using a Transaxillary Approach | January 2011 | February 2012 |
| NCT01384786 | Completed | The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter | October 2004 | July 2005 | |
| NCT01392222 | Completed | Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others | June 2011 | June 2017 | |
| NCT00124527 | Completed | Phase 2 | Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer | March 31, 2005 | August 31, 2006 |
| NCT01428167 | Completed | Hashimotos Thyroiditis and Thyroid Cancer | June 2011 | May 2012 | |
| NCT01433809 | Completed | Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm | June 2011 | May 2013 | |
| NCT01438554 | Completed | Phase 1 | Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma | October 2011 | August 2018 |
| NCT06283368 | Completed | Red Blood Cell Distributions (RDW, RDW-CW) and Lymphocyte Monocyte Ratios (LMR) for the Malignant Thyroid Nodules | January 2016 | January 2021 | |
| NCT01616316 | Completed | Phase 2/Phase 3 | Efficacy of Subfascial Approach in Thyroidectomy to Quality of Life in Thyroid Disease Patients | March 2010 | February 2012 |
| NCT01321554 | Completed | Phase 3 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC) | March 17, 2011 | March 19, 2019 |
| NCT00098345 | Completed | Phase 2 | Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer | November 2004 | April 19, 2017 |
| NCT00358956 | Completed | Phase 2 | A Study To Assess ZD6474 (ZACTIMA™) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer | August 2006 | May 2014 |
| NCT00423254 | Completed | Phase 1 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | February 2007 | November 2009 |
| NCT00428220 | Completed | N/A | A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. | July 2007 | September 2014 |
| NCT00439478 | Completed | Dental Safety Profile of High-Dose Radioiodine Therapy | September 2004 | September 2006 | |
| NCT00454077 | Completed | rhTSH-Thyroid Ablation With 1850 MBq of 131I | December 2004 | September 2006 | |
| NCT00480428 | Completed | Radiation Exposure and Thyroid Disease in Kazakhstan | May 17, 2007 | August 17, 2017 | |
| NCT00568438 | Completed | Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample | October 2000 | December 31, 2015 | |
| NCT00581815 | Completed | Phase 1 | Spectroscopy With Surface Coils and Decoupling | February 1997 | February 2014 |
| NCT00598364 | Completed | Molecular Markers in Thyroid Cancer | February 2007 | October 2010 | |
| NCT00604318 | Completed | Phase 4 | Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer | February 2008 | February 2012 |
| NCT00615537 | Completed | N/A | Pilot Study on Laser Ablation of Symptomatic Benign Thyroid Masses | February 2008 | January 2011 |
| NCT00704730 | Completed | Phase 3 | Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer | June 2008 | September 2020 |
| NCT00718770 | Completed | Early Phase 1 | A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression | November 2008 | February 2013 |
| NCT00719615 | Completed | Assess Vitamin D Levels in Those With & Without Thyroid Cancer | May 28, 2008 | June 1, 2009 | |
| NCT00784303 | Completed | Phase 2 | Evaluating the Safety and Efficacy of Oral Lenvatinib in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology | November 6, 2008 | March 29, 2019 |
| NCT06439745 | Completed | More Than 50% of the Patients With Clinically Unifocal T1b/Small T2 Node Negative Papillary Thyroid Carcinoma Scheduled for Thyroid Lobectomy May Require Completion Thyroidectomy if the Nodal Status is Evaluated | September 1, 2014 | February 1, 2024 | |
| NCT00794053 | Completed | Phase 3 | The Usefulness of Staining Lymph Nodes During Operations for Cancer Thyroid in Detecting the Nodes That Have Cancer | December 2002 | April 2009 |
| NCT00795782 | Completed | Phase 3 | Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma | January 2009 | June 2014 |
| NCT00887107 | Completed | Phase 2 | Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma | October 2007 | |
| NCT00896454 | Completed | Phase 2 | Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium | November 16, 2009 | August 21, 2013 |
| NCT00080574 | Completed | Phase 2 | The Effect of Thyroid Hormone on Drug Elimination in Cancer Patients | April 2004 | November 2005 |
| NCT00936858 | Completed | Phase 2 | RAD001 for Patients With Radioiodine Refractory Thyroid Cancer | July 2009 | February 27, 2020 |
| NCT06432257 | Completed | The Effect of the Application of Head Mounted Magnifying Glasses on Postoperative PTH Changes in Thyroid Surgery | January 1, 2020 | May 1, 2024 | |
| NCT06432244 | Completed | The Effect of the Number of Central Lymph Nodes on Changes in Parathyroid Function | January 1, 2020 | May 1, 2024 | |
| NCT00970359 | Completed | N/A | Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244 | September 2009 | April 2013 |
| NCT01728623 | Completed | Phase 2 | A Study of E7080 in Subjects With Advanced Thyroid Cancer | September 3, 2012 | October 1, 2015 |
| NCT01736163 | Completed | A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 Tumours | May 2012 | August 2012 | |
| NCT01792492 | Completed | The Role of an Optical Probe in Thyroid Cancer Diagnosis: Pilot Study | June 2009 | November 2015 | |
| NCT01833650 | Completed | N/A | The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer | May 2013 | September 2018 |
| NCT01840332 | Completed | N/A | Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer | April 2013 | February 2014 |
| NCT01882816 | Completed | Phase 2 | Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer | June 13, 2013 | November 4, 2021 |
| NCT01907997 | Completed | N/A | Effects of Systemic Lidocaine on Postoperative Quality of Recovery After Robot-assisted Thyroidectomy | July 2013 | May 2015 |
| NCT01964144 | Completed | Phase 2 | An Open-label, Multicenter, Phase II Study of Dovitinib in Advanced Thyroid Cancer | January 2013 | October 2014 |
| NCT01964508 | Completed | microRNA in Thyroid Cancer | September 12, 2013 | December 30, 2015 | |
| NCT00176748 | Completed | Phase 2 | Treatment for Patients With Metastatic Thyroid Cancer | July 2005 | June 2009 |
| NCT02012686 | Completed | N/A | The Effect of Transcutaneous Electrical Nerve Stimulation on Posterior Neck Pain After Thyroidectomy | November 2013 | February 2014 |
| NCT02018276 | Completed | N/A | Effect of Perioperative Intravenous Lidocaine Infusion and Magnesium Infusion on the Functional Recovery After General Anesthesia in the Patients Undergoing Thyroid Surgery | December 2013 | October 2014 |
| NCT02084732 | Completed | Phase 2 | Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study | October 1, 2013 | November 1, 2019 |
| NCT02223052 | Completed | Phase 1 | Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies | October 27, 2014 | December 18, 2018 |
| NCT02244463 | Completed | Phase 1/Phase 2 | A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer | July 2015 | April 28, 2022 |
| NCT02347683 | Completed | Optimal Measurement of Thyroglobulin Measurement Following Thyroidectomy | January 1, 2015 | February 1, 2016 | |
| NCT02375451 | Completed | Effect of Childhood Radioiodine Therapy on Salivary Function | September 2014 | September 2016 | |
| NCT02383927 | Completed | Phase 2 | Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations | March 2015 | November 30, 2020 |
| NCT02390934 | Completed | Phase 2 | Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer | October 1, 2014 | April 2, 2019 |
| NCT00181168 | Completed | Phase 2 | Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer | March 2001 | September 2003 |
| NCT02456701 | Completed | Phase 1 | Enhancing Radioiodine Incorporation Into BRAF Mutant Thyroid Cancers With the Combination of Vemurafenib and KTN3379 | June 2015 | October 13, 2016 |
| NCT00223158 | Completed | N/A | Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer | September 2003 | May 2005 |
| NCT02515084 | Completed | Phase 2 | Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma | March 2011 | July 2016 |
| NCT00251316 | Completed | Phase 2 | Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer | November 2005 | December 2011 |
| NCT02658513 | Completed | Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer | September 2016 | March 2019 | |
| NCT02702388 | Completed | Phase 2 | A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile | June 8, 2017 | September 10, 2020 |
| NCT02724176 | Completed | N/A | Potential Role for Carbon Nanoparticles to Guide Central Neck Dissection in Patients With Papillary Thyroid Cancer | January 2012 | January 2016 |
| NCT02731352 | Completed | Phase 2 | Study of Apatinib in Patients With Differentiated Thyroid Cancer | March 11, 2016 | February 28, 2021 |
| NCT02758158 | Completed | N/A | Tri-modal Imaging Instrument for Thyroid Cancer | January 2016 | February 2017 |
| NCT00339716 | Completed | Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Belarus Following the Chernobyl Accident | March 21, 1994 | March 11, 2020 | |
| NCT02862470 | Completed | Anaplastic Thyroid Cancer and Follicular Thyroid Cancer-derived Exosomal Analysis Via Treatment of Lovastatin and Vildagliptin and Pilot Prognostic Study Via Urine Exosomal Biological Markers in Thyroid Cancer Patients | August 5, 2016 | August 24, 2020 | |
| NCT02878044 | Completed | N/A | Shared Decision Making in Patients With Thyroid Nodules | August 18, 2016 | May 23, 2019 |
| NCT02911155 | Completed | Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists | September 21, 2016 | May 1, 2020 | |
| NCT00341094 | Completed | Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Ukraine Following the Chernobyl Accident | May 1, 1995 | October 8, 2020 | |
| NCT02947035 | Completed | Phase 2 | Molecular Testing to Direct Extent of Initial Thyroid Surgery | February 1, 2017 | June 1, 2023 |
| NCT00341185 | Completed | Studies of Thyroid Abnormalities in Northeastern Kazakhstan Associated With Nuclear Weapons Testing | March 5, 1998 | November 18, 2016 | |
| NCT06161233 | Completed | N/A | Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy | May 16, 2023 | January 31, 2024 |
| NCT02988817 | Completed | Phase 1/Phase 2 | Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors | November 23, 2016 | November 12, 2021 |
| NCT03024151 | Completed | N/A | The Effects of T4 Versus T4/T3 on Psychological Distress After Total Thyroidectomy in Thyroid Cancer Patients | December 2016 | November 2017 |
| NCT03031639 | Completed | Khon Kaen University's Thyroidectomy Registry | January 13, 2017 | January 12, 2021 | |
| NCT00342407 | Completed | The Incidence of Breast and Other Cancers Among Female Flight Attendants | November 6, 2001 | April 9, 2020 | |
| NCT03127098 | Completed | Phase 1/Phase 2 | QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer | June 26, 2017 | December 7, 2017 |
| NCT03294005 | Completed | Clinical Prediction Thyroid Cancer With Thyroid Ultrasonography | July 1, 2017 | June 30, 2020 | |
| NCT03300284 | Completed | Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer | August 7, 2017 | July 13, 2023 | |
| NCT03363347 | Completed | BRAF V600E and Redifferentiation Therapy in Radioiodine-refractory Papillary Thyroid Cancer | January 1, 2008 | December 31, 2014 | |
| NCT06124469 | Completed | UNN-RADS Scale for Diagnosing Lymph Node Metastasis in Patients With History of Thyroid Cancer | March 15, 2022 | November 1, 2023 | |
| NCT03392402 | Completed | Molecular Classifier for the Fine Needle-based Assessment of Malignancy Risk in Thyroid Nodules | January 1, 2017 | December 31, 2020 | |
| NCT03397238 | Completed | Myeloid Cell Reprogramming in Thyroid Carcinoma | March 6, 2018 | January 5, 2021 | |
| NCT03469310 | Completed | Phase 4 | Minimizing Narcotic Analgesics After Endocrine Surgery | March 9, 2018 | October 2, 2020 |
| NCT03488134 | Completed | Predicting Prognosis and Recurrence of Thyroid Cancer Via New Biomarkers, Urinary Exosomal Thyroglobulin and Galectin-3 | August 3, 2018 | February 20, 2024 | |
| NCT00342446 | Completed | A Follow-up Study of Women Evaluated and Treated for Infertility | October 1, 1995 | January 11, 2023 | |
| NCT03787121 | Completed | Estimation of Economic Consequences Linked With Different Care Management Pathways of Differentiated Thyroid Cancers | April 1, 2019 | December 31, 2020 | |
| NCT03969108 | Completed | Phase 4 | Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment | August 6, 2019 | November 13, 2019 |
| NCT04072731 | Completed | SREBP1 as a Potential Biomarker Promotes Cell Proliferation and Invasion in Thyroid Cancer | January 16, 2016 | January 1, 2018 | |
| NCT04274829 | Completed | Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid | January 2010 | February 2020 | |
| NCT04281875 | Completed | N/A | Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy. | March 16, 2020 | February 23, 2024 |
| NCT05684029 | Completed | Near-Infrared Autofluorescence With PTH Test Strip as an SOP of Parathyroid in Thyroid Surgery | November 1, 2022 | October 31, 2023 | |
| NCT04425512 | Completed | N/A | Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Thyroid Malignancy | November 1, 2014 | November 1, 2019 |
| NCT04462471 | Completed | Phase 1 | Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers | June 26, 2020 | September 29, 2023 |
| NCT04594720 | Completed | Circulating Biomarkers to Identify Thyroid Cancer | October 1, 2018 | September 30, 2020 | |
| NCT04601298 | Completed | The Risk Stratification of Papillary Thyroid Cancer With AUS/FLUS by FNA | August 1, 2015 | September 30, 2020 | |
| NCT04742959 | Completed | Phase 1/Phase 2 | Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | March 14, 2021 | February 20, 2024 |
| NCT04782856 | Completed | Phase 2 | Energy Metabolism in Thyroidectomized Patients | October 28, 2020 | April 19, 2023 |
| NCT04821336 | Completed | Cholesterol Metabolites Analysis in Human Thyroid and Iodine Resistance | April 15, 2021 | December 31, 2022 | |
| NCT04876287 | Completed | Salivary dysfuncTion After Radioiodine Treatment | September 2, 2020 | April 26, 2021 | |
| NCT04922801 | Completed | Optimising Molecular Radionuclide Therapy | December 9, 2021 | November 5, 2022 | |
| NCT05054634 | Completed | Psycho-oncological Intervention Through Counselling in Patients With Differentiated Thyroid Cancer in Treatment With Radioiodine | June 1, 2013 | March 31, 2015 | |
| NCT05131815 | Completed | N/A | The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors | January 10, 2022 | August 21, 2023 |
| NCT05132478 | Completed | N/A | The Effect of Surgeon Emotional Support on Treatment Choice for Low-risk Thyroid Cancer | November 17, 2021 | February 7, 2023 |
| NCT05377736 | Enrolling by invitation | N/A | Thyroid Nodule Gene Sequencing in a Danish Population | March 1, 2022 | January 18, 2027 |
| NCT04040673 | Not yet recruiting | RAman For Thyroid cancER | June 1, 2024 | June 1, 2025 | |
| NCT05428371 | Not yet recruiting | Assessment the Cancer Risk of Indeterminate Thyroid Nodules Through Integration of Clinical, Ultrasonographic and Multiomic Features | January 1, 2023 | December 31, 2027 | |
| NCT05468554 | Not yet recruiting | Phase 3 | Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid Cancer | November 1, 2022 | April 30, 2026 |
| NCT06101043 | Not yet recruiting | N/A | PECS II Block and Single Port Robot-assisted Transaxillary Thyroidectomy | January 4, 2024 | September 30, 2024 |
| NCT05758025 | Not yet recruiting | N/A | A New Surgical Strategy to Protect the Inferior Parathyroid | March 1, 2023 | June 1, 2024 |
| NCT06134830 | Not yet recruiting | Differentiated Thyroid Cancer Patients Treated With Different Doses of Radioactive Iodine. | March 1, 2024 | January 1, 2027 | |
| NCT06269731 | Not yet recruiting | Anxiety & Depression in Thyroid Cancer Patients | March 2024 | March 2026 | |
| NCT06411834 | Not yet recruiting | N/A | Mapping Patient Decision-making in Thyroid Cancer | January 2025 | January 2027 |
| NCT06220656 | Not yet recruiting | N/A | TRAIL Study: Feasibility and Pilot | March 2024 | June 2027 |
| NCT06455371 | Not yet recruiting | N/A | Patient-centered Dosage of Levothyroxine | August 2024 | December 2027 |
| NCT06146985 | Not yet recruiting | Phase 2 | Famitinib in Combination With Adebrelimab for the Treatment of Advanced Thyroid Cancer | December 1, 2023 | May 1, 2025 |
| NCT06261190 | Not yet recruiting | Active Surveillance for Low-risk Papillary Thyroid Carcinoma | March 4, 2024 | December 31, 2032 | |
| NCT05446441 | Not yet recruiting | N/A | Endoscopic Thyroidectomy Versus Open Thyroidectomy for Papillary Thyroid Carcinoma | June 28, 2022 | August 31, 2025 |
| NCT05323669 | Not yet recruiting | Molecular Profile of Thyroid Nodules | April 11, 2022 | December 31, 2024 | |
| NCT05275374 | Not yet recruiting | Phase 1/Phase 2 | XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation | December 2024 | December 2026 |
| NCT03570021 | Recruiting | Phase 3 | ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer | August 8, 2018 | October 2029 |
| NCT06007924 | Recruiting | Phase 2 | A Study of Avutometinib and Defactinib in People With Thyroid Cancer | August 16, 2023 | August 16, 2027 |
| NCT03624751 | Recruiting | Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment | June 30, 2018 | June 30, 2030 | |
| NCT05088187 | Recruiting | Cognition and QoL After Thyroid Surgery | January 17, 2023 | November 1, 2026 | |
| NCT05999630 | Recruiting | Phase 3 | Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer | August 21, 2023 | December 31, 2027 |
| NCT03676348 | Recruiting | HRQOL in Thyroid Cancer and Thyroid Tumours | January 25, 2018 | April 2028 | |
| NCT05932121 | Recruiting | Cross-sectional Case and Control Study on Quality of Life, Appearance and Functions in PTC Via Different Surgical Approach | June 25, 2023 | July 31, 2024 | |
| NCT03765333 | Recruiting | GETNE Registration of Thyroid Cancer | May 28, 2019 | December 2023 | |
| NCT05218395 | Recruiting | Association Between Persistent Organic Pollutants and Type 2 Diabetes /Thyroid Cancer | December 20, 2021 | December 30, 2025 | |
| NCT05864144 | Recruiting | Phase 1/Phase 2 | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors | May 31, 2023 | June 2027 |
| NCT06322160 | Recruiting | The Role of tHyroid cAncer Specific Patient Concerns iNventory (PCI-TC) in Enhancing Shared decisiOn Making | May 3, 2023 | December 31, 2024 | |
| NCT03830242 | Recruiting | N/A | Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer. | November 1, 2018 | December 31, 2024 |
| NCT03841617 | Recruiting | Phase 2 | The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer | July 29, 2019 | February 1, 2029 |
| NCT03905369 | Recruiting | N/A | Focus on Values to Stimulate Shared Decisions | March 1, 2020 | March 1, 2024 |
| NCT03942380 | Recruiting | N/A | Cell-free Tumor DNA in Head and Neck Cancer Patients | February 1, 2017 | February 1, 2025 |
| NCT05541380 | Recruiting | A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients (TOPICS-THYROID) | August 29, 2022 | December 31, 2030 | |
| NCT05851560 | Recruiting | Phase 1 | Prospective Comparison of the Effect on Antiadhesive Barriers During Thyroid or Parathyroid Surgery | May 24, 2023 | December 2023 |
| NCT05355701 | Recruiting | Phase 1 | A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. | July 5, 2022 | March 5, 2029 |
| NCT04028479 | Recruiting | The Registry of Oncology Outcomes Associated With Testing and Treatment | May 5, 2021 | October 1, 2031 | |
| NCT06254859 | Recruiting | Intraoperative Neuromuscular Monitoring and Its Impact on Pre- and Postoperative Acoustic Outcomes in Thyroid Surgery | March 1, 2024 | December 31, 2025 | |
| NCT05119296 | Recruiting | Phase 2 | Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer | February 15, 2022 | November 2026 |
| NCT04104529 | Recruiting | N/A | Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department | October 28, 2019 | October 2026 |
| NCT02012699 | Recruiting | Integrated Cancer Repository for Cancer Research | November 1, 2013 | December 2099 | |
| NCT04119024 | Recruiting | Phase 1 | Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors | November 27, 2019 | October 1, 2025 |
| NCT05837260 | Recruiting | Investigating Utility of ctDNA and Tumour Evolution in Advanced Thyroid Cancer | March 23, 2023 | February 7, 2027 | |
| NCT06239194 | Recruiting | Phase 1/Phase 2 | Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors | June 12, 2024 | February 2029 |
| NCT05824312 | Recruiting | HRQOL in Locally Advanced Thyroid Carcinoma | February 1, 2023 | January 31, 2026 | |
| NCT06236373 | Recruiting | The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia | April 20, 2023 | October 2024 | |
| NCT04136912 | Recruiting | Phase 2 | 3-D Super Resolution Ultrasound Microvascular Imaging | May 26, 2022 | October 2024 |
| NCT05796960 | Recruiting | European Multicenter Study on Surgical Management of Advanced Thyroid Cancer | December 15, 2022 | September 2023 | |
| NCT04238624 | Recruiting | Phase 2 | Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer | January 20, 2020 | June 20, 2024 |
| NCT05786924 | Recruiting | Phase 1 | A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers | April 18, 2023 | December 2026 |
| NCT05182931 | Recruiting | Phase 2 | A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study) | July 14, 2022 | December 30, 2025 |
| NCT05538130 | Recruiting | Phase 1 | A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors | November 30, 2022 | September 28, 2028 |
| NCT04285476 | Recruiting | N/A | Predictive Value of microRNA in Thyroid Cytologies of Undetermined Type | June 17, 2021 | December 2026 |
| NCT04290663 | Recruiting | Phase 3 | Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up | March 2, 2020 | February 2033 |
| NCT06222606 | Recruiting | N/A | Surgery for Thyroid Cancer With or Without Autofluorescence to Prevent Hypoparathyroidism | January 2024 | January 2026 |
| NCT02628067 | Recruiting | Phase 2 | Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) | December 18, 2015 | May 4, 2027 |
| NCT05774535 | Recruiting | Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery | September 5, 2022 | September 2024 | |
| NCT06363123 | Recruiting | Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis | March 29, 2024 | April 2025 | |
| NCT05752604 | Recruiting | Impact of Conventional Treatments and Clinical Variables on Thyroid Cancer | July 12, 2022 | March 8, 2042 | |
| NCT05747365 | Recruiting | Role of Endocrine Disruptors in Thyroid Cancer | July 12, 2022 | July 31, 2025 | |
| NCT05733013 | Recruiting | A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer | February 7, 2023 | February 7, 2028 | |
| NCT02747888 | Recruiting | N/A | Hereditary Risk Factors for Thyroid Cancer | March 1, 2016 | March 1, 2029 |
| NCT05708950 | Recruiting | Phase 1/Phase 2 | A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) | March 3, 2023 | December 31, 2024 |
| NCT04916990 | Recruiting | N/A | Improving Care for Rural Patients With Solid Tumors | September 1, 2022 | June 30, 2026 |
| NCT05463107 | Recruiting | Correlation Between Various Urinary Exosomal Protein Biomarkers and Pathological Manifestation in Thyroid Follicular Neoplasm: Early and Pre-operative Diagnosis of Follicular Thyroid Cancer | August 1, 2022 | July 31, 2028 | |
| NCT05510609 | Recruiting | N/A | Three-dimensional Ultrasonography Thyroid Volume Measurement. | May 9, 2022 | November 1, 2022 |
| NCT04952493 | Recruiting | Phase 2 | Anlotinib or Penpulimab in Combination With RAI for DTC | September 15, 2021 | July 20, 2024 |
| NCT04472026 | Recruiting | N/A | AIM1: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid | July 16, 2020 | June 30, 2025 |
| NCT04481893 | Recruiting | N/A | Interest of the Virtual Reality Headset in the Management of Perioperative Stress in Patients Candidates for Total Thyroidectomy | November 18, 2020 | June 2025 |
| NCT05275946 | Recruiting | Phase 1 | Targeted Alpha Therapy Using Astatine (At-211) Against Differentiated Thyroid Cancer | November 20, 2021 | September 30, 2025 |
| NCT05668962 | Recruiting | Phase 2 | Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC | March 1, 2023 | January 1, 2025 |
| NCT06158360 | Recruiting | An Observational Study on Postoperative Symptoms After Thyroidectomy (POS-T) | December 1, 2023 | December 31, 2024 | |
| NCT05253053 | Recruiting | Phase 1/Phase 2 | To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | April 13, 2022 | December 2024 |
| NCT05659186 | Recruiting | Phase 2 | PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer | December 30, 2022 | December 30, 2025 |
| NCT05620134 | Recruiting | Phase 1/Phase 2 | Study of JK08 in Patients With Unresectable Locally Advanced or Metastatic Cancer | October 17, 2022 | February 20, 2026 |
| NCT06149637 | Recruiting | N/A | Lateral Cervical Node Dissection in Differentiated Thyroid Cancer. | August 1, 2023 | August 31, 2028 |
| NCT03175224 | Recruiting | Phase 2 | APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors | September 27, 2017 | November 30, 2026 |
| NCT00001160 | Recruiting | Studies on Tumors of the Thyroid | June 1, 1977 | ||
| NCT06443866 | Recruiting | I-124 PET/CT Imaging and Dosimetry for RAI-Naïve or Refractory Thyroid Cancer | February 1, 2022 | December 2029 | |
| NCT06465017 | Recruiting | N/A | ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer | June 12, 2024 | June 30, 2026 |
| NCT04948437 | Recruiting | Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer | August 19, 2021 | October 31, 2026 | |
| NCT04463719 | Recruiting | N/A | AIM2: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid | February 20, 2022 | June 30, 2025 |
| NCT05583097 | Recruiting | N/A | The Ultracyt Study - is EU-TIRADS Useful in Selecting Nodules for Fine Needle Aspiration Cytology? | February 15, 2022 | December 31, 2023 |
| NCT04623801 | Recruiting | Phase 2 | Laser Ablation of Papillary Thyroid Microcarcinoma | October 19, 2020 | October 2025 |
| NCT04706962 | Recruiting | Phase 1 | TH1902 in Patients With Advanced Solid Tumors | March 4, 2021 | December 2024 |
| NCT06087068 | Recruiting | Phase 2 | Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma | August 1, 2022 | December 31, 2026 |
| NCT03432299 | Recruiting | N/A | Radiofrequency Ablation of Low Risk Papillary Thyroid Microcarcinoma | April 16, 2018 | December 31, 2023 |
| NCT06082180 | Recruiting | Phase 3 | A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer | July 1, 2022 | December 31, 2026 |
| NCT06073223 | Recruiting | N/A | Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer | September 18, 2023 | April 2025 |
| NCT03475953 | Recruiting | Phase 1/Phase 2 | A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors | May 4, 2018 | December 31, 2025 |
| NCT03483337 | Recruiting | New MRI Biomarkers in Head and Neck Cancers | March 16, 2018 | March 2025 | |
| NCT05412680 | Recruiting | N/A | Transoral Endoscopic Thyroidectomy by Vestibular Approach (TOETVA) | May 25, 2022 | December 31, 2024 |
| NCT05172921 | Recruiting | Environmental Factors and Thyroid Cancer | February 17, 2022 | February 2030 | |
| NCT06048367 | Recruiting | Phase 1 | Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor | October 14, 2022 | February 29, 2024 |
| NCT03517579 | Recruiting | N/A | Personalized Treatment in Thyroid Disorders | December 11, 2018 | December 15, 2024 |
| NCT06037174 | Recruiting | Comparison of Quality of Life in Patients With Differentiated Thyroid Carcinoma Undergoing Different Surgery | September 15, 2023 | September 10, 2025 | |
| NCT05366881 | Recruiting | cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease | May 3, 2022 | December 2026 | |
| NCT03360890 | Recruiting | Phase 2 | Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors | March 26, 2018 | September 2032 |
| NCT05399953 | Recruiting | N/A | Investigation of Effects of Physiotherapy Interventions on Mechanical Properties of Muscle in Head and Neck Cancer | November 10, 2022 | November 1, 2023 |
| NCT03139747 | Suspended | Phase 2 | UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone | April 3, 2017 | May 30, 2022 |
| NCT00804830 | Terminated | Phase 2 | Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer | April 2008 | December 2014 |
| NCT00115739 | Terminated | Phase 2 | Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma | February 2004 | August 2010 |
| NCT00354523 | Terminated | Phase 1/Phase 2 | Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma | December 2004 | August 2013 |
| NCT00926978 | Terminated | N/A | Comparison of Iodine-124 (I-124) and Iodine-131 (I-131) Radiopharmacokinetics in Patients Prepared With Recombinant Human TSH Injection (rhTSH) | December 2008 | October 2018 |
| NCT01265381 | Terminated | Thyroid Cancer Among Chornobyl Clean-up Workers in Ukraine: Pilot Study | December 22, 2010 | February 26, 2020 | |
| NCT01403324 | Terminated | N/A | Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer | September 2011 | June 2016 |
| NCT02012231 | Terminated | Phase 1 | Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers. | February 2014 | June 2015 |
| NCT02408887 | Terminated | Phase 2 | Total Thyroidectomy With and Without Prophylactic Central Neck Lymph Node Dissection in People With Low-risk Papillary Thyroid Cancer | April 15, 2015 | May 7, 2019 |
| NCT02472080 | Terminated | Phase 2 | Gemcitabine - Oxaliplatin for Advanced Refractory Thyroid Cancer Patients: a Phase II Study | April 7, 2016 | January 15, 2019 |
| NCT02628535 | Terminated | Phase 1 | Safety Study of MGD009 in B7-H3-expressing Tumors | September 2015 | November 25, 2019 |
| NCT02778412 | Terminated | ctDNA in Patients With Thyroid Nodules | May 2016 | August 2017 | |
| NCT02946918 | Terminated | Phase 4 | Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy | February 1, 2017 | November 4, 2019 |
| NCT02947399 | Terminated | N/A | Comparison of I-124 and I-131 Radiopharmacokinetics in DTC Patients With Thyroid Hormone Withdrawal | November 2008 | October 2018 |
| NCT03065218 | Terminated | Phase 4 | 99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients | October 2016 | February 15, 2021 |
| NCT03630120 | Terminated | Phase 2 | Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer | August 6, 2018 | December 5, 2019 |
| NCT05395429 | Unknown status | Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients | March 25, 2022 | December 15, 2023 | |
| NCT05265819 | Unknown status | N/A | Effect of Exergaming Exercises and Mediterranean Diet on Thyroid Cancer Patients Following Total Thyroidectomy | March 1, 2022 | December 5, 2022 |
| NCT05252884 | Unknown status | N/A | Calcium+Calcitriol Versus PTH for the Prevention of Hypocalcemia in Thyroidectomy. Randomized Clinical Trial | March 30, 2022 | December 2023 |
| NCT05124938 | Unknown status | Assessment of CA 19-9 in Patients' With Thyroid Malignancies | December 1, 2021 | December 1, 2022 | |
| NCT05025046 | Unknown status | NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules | September 2021 | June 2022 | |
| NCT04931576 | Unknown status | N/A | No Drainage During Transoral Endoscopic Thyroidectomy Vestibular Approach(TOETVA) | July 1, 2021 | October 1, 2023 |
| NCT04904159 | Unknown status | Scoring System for Thyroid Gland Pathologies | May 1, 2021 | May 1, 2023 | |
| NCT01374659 | Unknown status | Diagnostic Utility of [18F]-FDG-PET/CT and [124I]-PET/CT for Detection of Recurrence in Differentiated Thyroid Carcinoma | July 2009 | August 2012 | |
| NCT01307761 | Unknown status | An Easy Sonographic Scoring System for Predicting Malignant Thyroid Nodules | December 2010 | August 2013 | |
| NCT01043107 | Unknown status | Relationship Between Computer and Cancer | February 2010 | ||
| NCT00948337 | Unknown status | Phase 2 | A Study With Health Educational Material on Health Promotion in Cancer Survivors | August 2009 | December 2010 |
| NCT00786552 | Unknown status | Phase 2 | Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer | November 2008 | November 2013 |
| NCT00687778 | Unknown status | 11C-Acetate PET/CT Non-FDG-Avid Tumors | May 2008 | June 2010 | |
| NCT00435851 | Unknown status | Phase 3 | Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients | February 2007 | |
| NCT04853680 | Unknown status | N/A | Effect of Anti-adhesion Barrier on the Voice Quality After Thyroidectomy. | July 1, 2021 | July 30, 2023 |
| NCT04612894 | Unknown status | Phase 2 | Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer | December 1, 2020 | December 31, 2023 |
| NCT04560426 | Unknown status | N/A | Protective Effect of Intraoperative Parathyroid Gland Auxiliary Recognition System in Thyroid Malignant Tumor Operation | October 31, 2020 | October 31, 2022 |
| NCT04554680 | Unknown status | Phase 2 | Clinical Trial in RAI-Refractory Thyroid Carcinoma Evaluating BRAF & MEK Blockade for Re-differentiation Therapy | December 30, 2020 | April 2022 |
| NCT04524884 | Unknown status | Phase 2 | Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study | October 1, 2020 | September 30, 2022 |
| NCT04424485 | Unknown status | N/A | Near-infrared Fluorescence With Indocyanine Green for Identification of Sentinels and Parathyroids During Thyroidectomy | June 1, 2020 | June 1, 2021 |
| NCT04410601 | Unknown status | N/A | Post-thyroidectomy Dysphagia: An International Multicentric CONSORT - Compatible RCT | May 14, 2020 | June 2021 |
| NCT04396912 | Unknown status | Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort | May 15, 2020 | June 1, 2021 | |
| NCT04339478 | Unknown status | Does Parathyroid Autofluorescence Reduces Unintensional Parathyroidectomy During Total Thyroidectomy With Central Lymph Node Compartment Dissection | April 6, 2020 | August 30, 2022 | |
| NCT04320901 | Unknown status | N/A | Energy Device Study in Transoral Endoscopic Thyroidectomy | April 1, 2020 | February 28, 2023 |
| NCT04312087 | Unknown status | N/A | Lateral Neck Lymph Node Mapping in Thyroid Cancer | August 1, 2016 | December 31, 2022 |
| NCT04309136 | Unknown status | Phase 2 | Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer | June 1, 2019 | June 1, 2022 |
| NCT04248166 | Unknown status | N/A | Thyroid Cancer and Photoacoustic Imaging | January 1, 2020 | December 31, 2020 |
| NCT04141306 | Unknown status | Radioiodine-avid Bone Metastases From Thyroid Cancer Without Structural Abnormality | November 2019 | December 2019 | |
| NCT04133870 | Unknown status | Identification of Molecular Biomarkers for Thyroid Cancer | December 21, 2015 | July 30, 2020 | |
| NCT04128631 | Unknown status | Thyroid Cancer and (FDG)PET/CT Scan | October 30, 2019 | December 1, 2020 | |
| NCT03978351 | Unknown status | The Role of Midkine in Diagnosis of Thyroid Cancer | September 2019 | December 2020 | |
| NCT03826680 | Unknown status | N/A | Modified Cormack Lehane Scores Evaluated by Laryngoscopy During Awake Versus Under General Anesthesia | March 19, 2019 | July 2020 |
| NCT03680222 | Unknown status | N/A | Effect of Reversed Tracking Method for Identification of EBSLN in Thyroid Surgery | October 1, 2018 | September 30, 2020 |
| NCT03657654 | Unknown status | Voice Outcomes Following Thyroidectomy | April 23, 2019 | December 15, 2023 | |
| NCT03577951 | Unknown status | N/A | Comparing the Establishment of Operation Space Between High Position and Low Position in Endoscopic Thyroid Surgery | June 1, 2018 | October 31, 2018 |
| NCT03530033 | Unknown status | N/A | Lidocaine Reduces Muscle Tremor is Beneficial for Intraoperative Recurrent Laryngeal Nerve Monitoring | May 1, 2018 | October 31, 2018 |
| NCT03514251 | Unknown status | N/A | Study on Application of Suturing Parathyroid Markers in Thyroid Cancer Surgery | April 1, 2018 | September 30, 2018 |
| NCT03510143 | Unknown status | N/A | Effect of Polyglycolic Acid Mesh (Neoveil) in Thyroid Cancer Surgery | May 1, 2018 | December 31, 2020 |
| NCT03469544 | Unknown status | Long Non Coding RNA HOTAIR and Midkine as Biomarkers in Thyroid Cancer | March 29, 2018 | March 29, 2020 | |
| NCT03454464 | Unknown status | N/A | Evaluation of Central Compartment Dissection Without Thyroidectomy | January 1, 2018 | December 31, 2018 |
| NCT03411187 | Unknown status | N/A | Study on the Application of Convenient Foot-control Exhaust Method in Endoscopic Thyroidectomy | January 1, 2018 | December 30, 2018 |
| NCT03377829 | Unknown status | N/A | A Multicenter Trial of PLA vs. Surgery for Treating PTMC | December 1, 2017 | December 31, 2022 |
| NCT03375931 | Unknown status | N/A | The Effects of Preoperative Prayer on Postoperative Quality of Recovery in Patients Undergoing Thyroidectomy | December 15, 2017 | May 2020 |
| NCT03300765 | Unknown status | Phase 2 | Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer | July 1, 2017 | May 1, 2020 |
| NCT03268785 | Unknown status | N/A | Intra-operative Rapid Identification of Lymph Node and Parathyroid | August 1, 2016 | August 1, 2020 |
| NCT03170804 | Unknown status | Genomic Profiling of Nodular Thyroid Disease and Thyroid Cancer | January 1, 2017 | January 1, 2020 | |
| NCT03006289 | Unknown status | Relationship of Metabolic Syndrome and Its Components With Thyroid Cancer | December 2016 | November 2017 | |
| NCT02953288 | Unknown status | Differential Diagnosis and Clinical Treatment Strategies of Thyroid Nodules. | October 2016 | December 2018 | |
| NCT02602717 | Unknown status | N/A | The Evaluation of the Diagnostic Properties of Intra-operative In-situ Thyroglobin Levels of Cervical Lymph Nodes, in the Discrimination Between Benign and Malignant Lymph Nodes in Thyroid Cancer: a Prospective Multicentre Study. | February 18, 2013 | December 2018 |
| NCT02225509 | Unknown status | N/A | Clinical Validation of a Molecular Signature to Detect Cancer in Thyroid Nodules With Indeterminate Cytology | October 2014 | |
| NCT02156362 | Unknown status | N/A | Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis) | May 2012 | May 2023 |
| NCT01811199 | Unknown status | Dexamethasone Reduces Postoperative Emesis by Decreasing PGF2α and LTC4 Levels | February 2011 | May 2013 | |
| NCT01781767 | Unknown status | Changes in Metabolic Status in Patients With Total Thyroidectomy | January 2013 | July 2014 | |
| NCT01565486 | Unknown status | N/A | Safety and Efficacy Study of Ultrasonic Coagulation Device and Bipolar Energy Sealing System | August 2011 | August 2017 |
| NCT01512212 | Unknown status | N/A | New Thyroid Fine Needle Aspiration Biopsy Apparatus | January 2012 | September 2012 |
| NCT04868045 | Withdrawn | Phase 1 | Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer | April 27, 2021 | February 15, 2023 |
| NCT00954837 | Withdrawn | N/A | Assessment of Repeat Fine Needle Aspiration (FNA) to Detect Thyroid Cancer | April 2010 | December 2012 |
| NCT04224792 | Withdrawn | N/A | Effects of Exercise Training on Fatigue in Thyroid Cancer Survivors | September 30, 2022 | December 30, 2024 |
| NCT01994200 | Withdrawn | Phase 1/Phase 2 | Developing and Implementing an Interdisciplinary Team-Based Care Approach (ITCA-ThyCa) for Thyroid Cancer Patients | September 2014 | June 2016 |
| NCT02726282 | Withdrawn | Impact of Papillary Microcarcinoma Terminology on Patients Treatment Preferences: a Cross Sectional Survey | March 2016 | March 2017 | |
| NCT01153945 | Withdrawn | Association Between Cancer Cells and Normal Versus (Vs.) Low Levels of Thyroid Hormones in the Serum | February 2011 | July 2011 | |
| NCT00373711 | Withdrawn | Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA | May 2007 |
- Disase is a (Disease Ontology)
- DOID:170
- Cross Reference ID (Disease Ontology)
- ICD10CM:C73
- Cross Reference ID (Disease Ontology)
- ICD9CM:193
- Cross Reference ID (Disease Ontology)
- KEGG:05216
- Cross Reference ID (Disease Ontology)
- MESH:D013964
- Cross Reference ID (Disease Ontology)
- NCI:C3414
- Cross Reference ID (Disease Ontology)
- NCI:C7510
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:127018007
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:94098005
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0007115
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0040136
- Exact Synonym (Disease Ontology)
- malignant neoplasm of thyroid gland
- Exact Synonym (Disease Ontology)
- malignant tumour of thyroid gland
- Exact Synonym (Disease Ontology)
- neoplasm of thyroid gland
- Exact Synonym (Disease Ontology)
- thyroid gland cancer
- Exact Synonym (Disease Ontology)
- Thyroid gland neoplasm
- Exact Synonym (Disease Ontology)
- thyroid neoplasm